コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 otein has been identified and shown to be an immunophilin.
2 ggesting a cytoskeletal localization for the immunophilin.
3 tide repeat (TPR) domain protein, such as an immunophilin.
4 B transporters and the TWISTED DWARF1 (TWD1) immunophilin.
5 -binding proteins form the FKBP subfamily of immunophilins.
6 ved family of intracellular receptors called immunophilins.
7 in similar to the heat-shock protein-binding immunophilins.
8 o the FK-506 binding protein (FKBP) class of immunophilins.
9 pathways independent of calcineurin and the immunophilins.
10 d hormones, and on small molecules that bind immunophilins.
11 NA synthesis and in steroid receptor-binding immunophilins.
12 p23, and one of three high molecular weight immunophilins.
13 is inhibited by dominant factors related to immunophilins.
17 52 genes have been found to encode putative immunophilins, among which 23 are putative FKBPs and 29
20 ne-regulated FK506-binding protein 5 (FKBP5) immunophilin and small Ras family G protein cell growth
21 FKBP46 belongs to the high-molecular-weight immunophilins and shares many characteristic features wi
22 ential interactions between Hsp90-associated immunophilins and target proteins such as steroid recept
29 risk recipients, avoid immediate exposure to immunophilin antagonists, and perform biopsy frequently
30 Competition assays demonstrated that both immunophilins antagonize one another, and binding assays
31 ast, the high molecular weight hsp90-binding immunophilins appear to play a role in protein trafficki
42 unosuppressant, rapamycin, binds to the same immunophilin as FK506 but inactivates a protein kinase p
43 d, tetratricopeptide repeat (TPR)-containing immunophilin, associates with nascent plasma membrane io
47 o, nuclear movement of p53 is inhibited when immunophilin binding to dynein is competed for by expres
51 ntaining hsp90, hsp70, p60, p23, and several immunophilins can assemble steroid receptors and oncogen
53 racting protein (AIP), a survivin-associated immunophilin, causes embryonic lethality in mice by embr
54 does not express caveolin, does not form an immunophilin-caveolin complex, and does not transport ne
55 of caveolin is part of a heat-shock protein-immunophilin chaperone complex consisting of caveolin, h
59 c studies in mice for a potential role of an immunophilin cochaperone in the etiology of human endome
62 receptor engagement and dependent upon drug-immunophilin complexes and, presumably, calcineurin acti
63 study of glucocorticoid receptor (GR).hsp90.immunophilin complexes in mammalian cells, there is cons
65 se known to be the cellular target of ligand-immunophilin complexes, increase 3-fold during myogenesi
66 specifically inhibited by immunosuppressant immunophilin complexes, which enabled its function in re
67 ly shown that immunoadsorption of the FKBP52 immunophilin component of steroid receptor.hsp90 heteroc
69 omyces cerevisiae, CsA and FK506 bind to the immunophilins cyclophilin A and FKBP12 and the resulting
70 ous CrkII, but not CrkI, associates with the immunophilins, cyclophilin A, and 12-kDa FK506-binding p
74 (SQUINT) is the Arabidopsis ortholog of the immunophilin CyP40 (cyclophilin 40) and promotes microRN
77 suggesting that transcriptionally regulated, immunophilin-dependent but calcineurin-independent targe
79 ovide strong support for the hypothesis that immunophilin dFKBP59 is part of the TRPL-INAD signaling
83 Genetic evidence supports a model in which immunophilin-drug complexes inhibit calcineurin to preve
87 gs such as cyclosporin and FK506 defines the immunophilin family of proteins, and the FK506-binding p
90 ances made in understanding the role of each immunophilin family, cyclophilins, FK506 binding protein
91 e that cyclophilin A (CyPA), a member of the immunophilin family, is secreted by VSMCs in response to
93 , an agent that competes with FK-506 for the immunophilin, FK binding protein 12, does not inhibit ca
99 (i) the identification of a homologue of the immunophilin FKBP-12 with dorsal anterior expression in
100 1046, a non-immunosuppressive ligand of the immunophilin FKBP12 (FK-506-binding protein 12 kDa), has
105 ransition state for folding/unfolding of the immunophilin FKBP12 has been characterised using a combi
106 ough interaction screens have shown that the immunophilin FKBP12 interacts with TGF-beta type I recep
109 The data presented demonstrate that the immunophilin FKBP12 is present in retina and specificall
110 ere performed on rat retinal tissue, and the immunophilin FKBP12 was found to be present in retina.
113 omain of TRAF2 and TRAF6 with repeats of the immunophilin FKBP12, we demonstrate that their effector
127 Moreover, we demonstrate that the insect immunophilin FKBP46 can be phosphorylated by human and S
133 cation, while knockdown of FKBP5, coding for immunophilin FKBP51, was associated with increased basel
135 nding of hormone-induced substitution of one immunophilin (FKBP51) for another (FKBP52), and concomit
136 ation revealed two key binding proteins, the immunophilin FKBP52 and the beta1-subunit of L-type volt
137 idence that both hsp90 and the FK506-binding immunophilin FKBP52 play a role in receptor movement fro
140 iRNA knockdown of FKBP4 gene, coding for the immunophilin FKBP52, inhibited cortisol-activated GR nuc
141 90-organizing protein Hop, the FK506-binding immunophilins FKBP52 and FKBP51, the cyclosporin A-bindi
142 om DLD-1 human colon cancer cells contain an immunophilin (FKBP52, CyP-40, or PP5) as well as dynein.
143 is now clear that the large molecular weight immunophilins, FKBP52 and FKBP51, play important regulat
148 east Saccharomyces cerevisiae, the nucleolar immunophilin, Fpr3, is phosphorylated at tyrosine and de
154 ng support for the inositolphosphate-binding immunophilin having an apparent mass of 12 kD, and it is
155 B virus X-associated protein 2 (XAP2) is an immunophilin homolog and core component of the aryl hydr
156 nal half (amino acids 1-169), containing the immunophilin homology region, similarly reduced PDE4A5 a
157 m has been defined, and it is shown that key immunophilin (IMM) components of the trafficking machine
158 involved in the binding are common for both immunophilin-immunosuppressant complexes, a significant
159 in phosphatase, is the common target for two immunophilin-immunosuppressant complexes, cyclophilin A-
165 ther family of PPIases that are unrelated to immunophilins in protein sequences and drug binding prop
167 of differential roles for FKBP51 and FKBP52 immunophilins in the control of steroid receptor subcell
168 peptide repeat (TPR) proteins (also known as immunophilins) in hormone-free steroid receptor complexe
169 cyclosporin A and FK506, when complexed with immunophilins, inactivate the protein phosphatase calcin
173 that the PPIase domains of the hsp90-binding immunophilins interact directly with cytoplasmic dynein
176 Taken as a whole, these studies identify immunophilin interchange as the earliest known event in
178 omerase activity of this membrane-associated immunophilin is strongly inhibited by nanomolar concentr
180 he RyR because, to detect the receptor-bound immunophilin, it was necessary to add FKBP12 to the puri
181 similar amounts of cyclophilin A and FKBP12, immunophilins known to be intracellular-binding targets
182 GR reporter gene assays under conditions of immunophilin ligand and dexamethasone treatment that yie
183 scaffolds, and that both the identity of the immunophilin ligand and the linker chemistry affect comp
184 Furthermore, in this model, we show that the immunophilin ligand FK506 but not cyclosporin A prevents
185 de in the development of inhibitors based on immunophilin ligand polyketides, which target the TOR-me
187 ons also respond differentially to FK506, an immunophilin ligand with well-established neuroprotectiv
189 present report, a novel nonimmunosuppressive immunophilin ligand, GPI-1046 (3-(3-pyridyl)-1-propyl (2
190 irst step, we treated L929 cells with select immunophilin ligands [FK506, rapamycin, cyclosporin A (C
198 ep and diurnal rhythm regulation, effects of immunophilin ligands, and cell surface oligosaccharides
199 Agents such as phosphodiesterase inhibitors, immunophilin ligands, and recombinant human erythropoiet
200 ve and regenerative therapies, including the immunophilin ligands, hold promise to reduce the morbidi
201 pressive properties of these clinically used immunophilin ligands, this holds promise for the neuropr
203 et of rapamycin (mTOR) binding region yields immunophilin ligands, WYE-592 and ILS-920, with potent n
205 tudy reveals a novel functional role for the immunophilin-like component of a soluble receptor comple
207 he 90-kDa heat shock protein (hsp90) and the immunophilin-like hepatitis B X-associated protein 2 (XA
208 tor (AhR) has been shown to interact with an immunophilin-like molecule known as AhR-interacting prot
210 g protein (AIP) is a ubiquitously expressed, immunophilin-like protein best known for its role as a c
215 and we show by peptide competition that the immunophilins link via their tetratricopeptide repeat do
219 r heterocomplexes exist depending upon which immunophilin occupies the TPR-binding region of hsp90.
222 e, we ask if wheat germ lysate also contains immunophilins of the FK506-binding class (FKBPs) that bi
223 ant homologue to show that two hsp90-binding immunophilins of wheat, wFKBP73 and wFKBP77, bind to dyn
224 and so we examined in vivo the influences of immunophilins on hormone-dependent gene activation in th
225 ast mutant strains defective in calcineurin, immunophilins or other genes with the immunosuppressants
226 eterocomplexes that contain hsp90 and either immunophilins or, in the case of protein kinases, p50.
227 novel targets dependent upon calcineurin or immunophilins or, perhaps, specific targets of either Cy
228 nsity to dynamically associate with an Hsp90-immunophilin-p23 complex through its regulatory domain.
229 tively compete with trimeric hHSF1 for Hsp90-immunophilin-p23 complex, counteracting assembly of the
230 of genomic DNA encoding Schistosoma mansoni immunophilin p50 (Smp50) was identified on a 14-kb genom
232 in indirectly through the association of the immunophilin peptidylprolyl isomerase (PPIase) domain wi
237 lin A (CyP-A) is a relatively abundant small immunophilin present in the cytoplasm of all mammalian c
239 tion between the activin receptor R1 and the immunophilin protein FKBP12 can be disrupted by the smal
241 ar mass of approximately 52 kDa (FKBP52), an immunophilin protein that interacts with physiological T
242 sociation of Ras with ubiquitously expressed immunophilin proteins such as FKBP12 and cyclophilin A.
244 plex of the immunosuppressant rapamycin, its immunophilin receptor Fpr1p and Tor1p or Tor2p results i
245 imus (FK506) bind to unrelated intracellular immunophilin receptors, cyclophilin (CyP) and FK506-bind
247 omplexes it is typically bound to one of the immunophilin-related co-chaperones: the peptidylprolyl i
248 is B virus X-associated protein 2 (XAP2), an immunophilin-related protein sharing homologous regions
250 Arabidopsis knock-out mutations in these immunophilins result in an increased susceptibility to P
254 two groups of proteins (collectively called immunophilins) share little sequence homology, but both
255 ing each of the TRPC proteins along with the immunophilins showed that TRPC3, -C6, and -C7 interact w
257 C3G) binding to CrkII, whereas inhibitors of immunophilins, such as cyclosporine A (CsA) and FK506, i
258 espectively), as well as high molecular mass immunophilins, such as FKBP59, and the small acidic prot
259 at contain TPR motifs include members of the immunophilin superfamily, organelle-targeting proteins,
260 FKBP52 is a steroid receptor-associated immunophilin that binds via a tetratricopeptide repeat (
261 e chaperones interact with Cyclophilin D, an immunophilin that induces mitochondrial cell death, and
262 FK506-binding protein 52 (FKBP52) is an immunophilin that possesses peptidylprolyl cis/trans-iso
263 FKBP52 is a widely expressed FK506-binding immunophilin that possesses peptidylprolyl isomerase act
264 06-binding protein 12.6/1b (FKBP1b), a small immunophilin that stabilizes RyR-mediated Ca2+ release i
265 y described progesterone receptor-associated immunophilin that, similar to FKBP52 and cyclophilin 40,
266 d animal cells contain high molecular weight immunophilins that bind via tetratricopeptide repeat (TP
269 m cells contain one of several hsp90-binding immunophilins that link the complex to cytoplasmic dynei
273 ADPH oxidase subunit p67 phox, hsp90-binding immunophilins, transcription factors, the PKR protein ki
274 of p53 or GR heterocomplexes with hsp90 and immunophilins was not affected by PFTalpha either in viv
276 this study was twofold: to determine whether immunophilins were present in the rat retina and to dete
277 Surprisingly, yeast mutants lacking all 12 immunophilins were viable, and the phenotype of the dode
280 n this study, we investigated the ability of immunophilins, which function as peptidyl-prolyl isomera
281 eterocomplexes in L cell cytosol contains an immunophilin with high affinity FK506 binding activity,
282 propose that PP5 possesses properties of an immunophilin with low affinity FK506 binding activity an
283 A shows homology to cyclophilins, a class of immunophilins with a peptidyl-prolyl cis-trans isomerase
285 ociated with FK506-binding proteins (FKBPs); immunophilins, with cis-trans peptidyl-prolyl isomerase
286 t belong to a subgroup of proteins, known as immunophilins, with peptidylprolyl cis-trans isomerase (
288 d inserted in the vicinity of genes encoding immunophilin, zinc finger protein Sma-Zic, and others, a